BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35012903)

  • 1. What is the impact of zinc deficiency for pancreatectomies in patients with pancreatic ductal adenocarcinoma?
    Iseki M; Mizuma M; Aoki S; Kawaguchi K; Masuda K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
    Pancreatology; 2022 Mar; 22(2):270-276. PubMed ID: 35012903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
    J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of preoperative renal insufficiency on postoperative outcomes after pancreatic resection: a single institution experience of 1,061 consecutive patients.
    Squires MH; Mehta VV; Fisher SB; Lad NL; Kooby DA; Sarmiento JM; Cardona K; Russell MC; Staley CA; Maithel SK
    J Am Coll Surg; 2014 Jan; 218(1):92-101. PubMed ID: 24211054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
    Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
    BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy of Pancreatectomies for Pancreatic Ductal Adenocarcinoma in Patients with a History of Gastrectomy.
    Amikura K; Ogura T; Takahashi A
    Tohoku J Exp Med; 2022 Apr; 256(4):337-348. PubMed ID: 35321979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.
    Krell RW; McNeil LR; Yanala UR; Are C; Reames BN
    Ann Surg Oncol; 2021 Jul; 28(7):3810-3822. PubMed ID: 33386542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative oncologic impact of poor postoperative pain control in left-sided pancreatic cancer.
    Min EK; Chong JU; Hwang HK; Pae SJ; Kang CM; Lee WJ
    World J Gastroenterol; 2017 Jan; 23(4):676-686. PubMed ID: 28216975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study.
    Gao H; Liu T; Wang G; Gao Y; Yin L; Peng Y; Lyu N; Zhang K; Gao W; Wu J; Jiang K; Wei J; Miao Y
    Langenbecks Arch Surg; 2019 Mar; 404(2):175-182. PubMed ID: 30826926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DUPAN-2 as a Risk Factor of Early Recurrence After Curative Pancreatectomy for Patients With Pancreatic Ductal Adenocarcinoma.
    Sasaki A; Sakata K; Nakano K; Tsutsumi S; Fujishima H; Futsukaichi T; Terashi T; Ikebe M; Bandoh T; Utsunomiya T
    Pancreas; 2023 Feb; 52(2):e110-e114. PubMed ID: 37523601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
    Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
    J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thirty-day complication rates do not differ by race among patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Mitsakos AT; Dennis SO; Parikh AA; Snyder RA
    J Surg Oncol; 2021 Mar; 123(4):970-977. PubMed ID: 33497474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients After Pancreaticoduodenectomy.
    Macías N; Sayagués JM; Esteban C; Iglesias M; González LM; Quiñones-Sampedro J; Gutiérrez ML; Corchete LA; Abad MM; Bengoechea O; Muñoz-Bellvis L
    J Clin Gastroenterol; 2018 Feb; 52(2):e11-e17. PubMed ID: 28059940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
    Fukumoto T; Watanabe T; Hirai I; Kimura W
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lack of postoperative complications after pancreatectomy contributes to the long-term survival of patients with pancreatic cancer.
    Kasahara N; Noda H; Kakizawa N; Kato T; Watanabe F; Ichida K; Endo Y; Aizawa H; Rikiyama T
    Pancreatology; 2019 Jul; 19(5):686-694. PubMed ID: 31253497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma.
    Xiong J; Wei A; Ke N; He D; Chian SK; Wei Y; Hu W; Liu X
    Int J Surg; 2017 Dec; 48():134-141. PubMed ID: 29081373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.
    Matsuda R; Miyasaka Y; Ohishi Y; Yamamoto T; Saeki K; Mochidome N; Abe A; Ozono K; Shindo K; Ohtsuka T; Kikutake C; Nakamura M; Oda Y
    Ann Surg; 2020 May; 271(5):941-948. PubMed ID: 30308608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Preoperative Inflammatory Markers in Pancreatectomy: a Norwegian Nationwide Cohort Study.
    Sahakyan MA; Kleive D; Dille-Amdam RG; Kjeseth T; Waardal K; Edwin B; Nymo LS; Lassen K
    J Gastrointest Surg; 2023 Aug; 27(8):1650-1659. PubMed ID: 37322265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.